146 related articles for article (PubMed ID: 15899316)
1. Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs.
Ware NC; Wyatt MA; Tugenberg T
Soc Sci Med; 2005 Aug; 61(3):565-76. PubMed ID: 15899316
[TBL] [Abstract][Full Text] [Related]
2. Bridging the gap between antiretroviral access and adherence in Mexico.
Campero L; Herrera C; Kendall T; Caballero M
Qual Health Res; 2007 May; 17(5):599-611. PubMed ID: 17478643
[TBL] [Abstract][Full Text] [Related]
3. The inability to take medications openly at home: does it help explain gender disparities in HAART use?
Sayles JN; Wong MD; Cunningham WE
J Womens Health (Larchmt); 2006 Mar; 15(2):173-81. PubMed ID: 16536681
[TBL] [Abstract][Full Text] [Related]
4. Challenges of adherence management in human immunodeficiency virus pharmacotherapy.
Park-Wyllie LY; Phillips EJ
Can J Clin Pharmacol; 2003; 10(4):189-95. PubMed ID: 14712324
[TBL] [Abstract][Full Text] [Related]
5. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.
Kapadia F; Vlahov D; Wu Y; Cohen MH; Greenblatt RM; Howard AA; Cook JA; Goparaju L; Golub E; Richardson J; Wilson TE
Am J Drug Alcohol Abuse; 2008; 34(2):161-70. PubMed ID: 18293232
[TBL] [Abstract][Full Text] [Related]
6. Treatment adherence to an antiretroviral regime: the lived experience of Native Hawaiians and kokua.
Ka'opua L
Pac Health Dialog; 2001 Sep; 8(2):290-8. PubMed ID: 12180508
[TBL] [Abstract][Full Text] [Related]
7. Overview and implementation of an intervention to prevent adherence failure among HIV-infected adults initiating antiretroviral therapy: lessons learned from Project HEART.
Davies G; Koenig LJ; Stratford D; Palmore M; Bush T; Golde M; Malatino E; Todd-Turner M; Ellerbrock TV
AIDS Care; 2006 Nov; 18(8):895-903. PubMed ID: 17012078
[TBL] [Abstract][Full Text] [Related]
8. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users.
Macalino GE; Hogan JW; Mitty JA; Bazerman LB; Delong AK; Loewenthal H; Caliendo AM; Flanigan TP
AIDS; 2007 Jul; 21(11):1473-7. PubMed ID: 17589194
[TBL] [Abstract][Full Text] [Related]
9. "It is not that I forget, it's just that I don't want other people to know": barriers to and strategies for adherence to antiretroviral therapy among HIV patients in Northern Vietnam.
Van Tam V; Pharris A; Thorson A; Alfven T; Larsson M
AIDS Care; 2011 Feb; 23(2):139-45. PubMed ID: 21259125
[TBL] [Abstract][Full Text] [Related]
10. Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy.
Lucas GM; Griswold M; Gebo KA; Keruly J; Chaisson RE; Moore RD
Am J Epidemiol; 2006 Mar; 163(5):412-20. PubMed ID: 16394200
[TBL] [Abstract][Full Text] [Related]
11. HIV-infected patients' adherence to highly active antiretroviral therapy: a phenomenological study.
Mohammadpour A; Yekta ZP; Nikbakht Nasrabadi AR
Nurs Health Sci; 2010 Dec; 12(4):464-9. PubMed ID: 21210925
[TBL] [Abstract][Full Text] [Related]
12. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
14. [Transmural care for HIV-seropositive drug users: experiences from Southeast Limburg, the Netherlands].
van der Ven AJ; Vermeulen CM; Schippers JA; Bruggeman CA; Satijn TK; Hospers HJ
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):662-5. PubMed ID: 12712651
[TBL] [Abstract][Full Text] [Related]
15. An adherence typology: coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment.
Bader A; Kremer H; Erlich-Trungenberger I; Rojas R; Lohmann M; Deobald O; Lochmann R; Altmeyer P; Brockmeyer N
Med Sci Monit; 2006 Dec; 12(12):CR493-500. PubMed ID: 17136004
[TBL] [Abstract][Full Text] [Related]
16. Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART).
Michel L; Giorgi R; Villes V; Poizot-Martin I; Dellamonica P; Spire B; Protopopescu C; Carrieri MP
Drug Alcohol Depend; 2009 Jan; 99(1-3):96-104. PubMed ID: 18774237
[TBL] [Abstract][Full Text] [Related]
17. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
Roux P; Carrieri MP; Cohen J; Ravaux I; Poizot-Martin I; Dellamonica P; Spire B
Clin Infect Dis; 2009 Nov; 49(9):1433-40. PubMed ID: 19807275
[TBL] [Abstract][Full Text] [Related]
18. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
[TBL] [Abstract][Full Text] [Related]
19. Predicting and monitoring antiretroviral adherence.
Gross R
LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
[TBL] [Abstract][Full Text] [Related]
20. Adherence practices among people living with HIV.
Adam BD; Maticka-Tyndale E; Cohen JJ
AIDS Care; 2003 Apr; 15(2):263-74. PubMed ID: 12856347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
